Patients News | pharmaphorum

News

Egetis has launched the first-ever therapy for the ultra-rare disease MCT8 deficiency in the US, with a list price of $950,000 per year.

News

UK biotech shrugged off a difficult economic environment with a 44% increase in venture capital investment in the third quarter to £270m, says BIA.

News

Two drugs hoping to muscle in on Amgen's first-to-market DLL3-targeting drug Imdelltra – from Zai Lab and Ideaya – have new trial readouts at ESMO.

News

US policy changes designed to curb drug prices seem ineffective, as the annual cost of new medicines still exceeds $250,000, curbing patient access.

News

Researchers have developed an AI model, trained on millions of facial images, that can directly predict survival risk in patients with cancer.

News

AstraZeneca has launched a project with tech giant Oracle that will use AI and real-world data to improve clinical research and patient care.